Related Experiment Videos
The folate receptor as a potential therapeutic anticancer target
1Department of Pediatrics, University of Texas Health Science Center, San Antonio 78284-7810, USA.
Investigational New Drugs
|June 9, 1999
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study.
European journal of cancer (Oxford, England : 1990)·2013
Liquid chromatography-mass spectrometry assay of a thiadiazole derivative in mice: application to pharmacokinetic studies.
Journal of chromatography. B, Biomedical sciences and applications·2002
Activity of MKT 077, a rhodacyanine dye, against human tumor colony-forming units.
Anti-cancer drugs·1999
Novel EGFR tyrosine kinase inhibitors exhibiting intrinsic fluorescence.
Investigational new drugs·2026
The novel agent VP79s synergistically enhances venetoclax activity in multiple myeloma cells.
Investigational new drugs·2026
Hydrogel-Nanoparticle Bioactive Platforms for Post-Surgical Prevention of Tumor Recurrence.
Nanomaterials (Basel, Switzerland)·2026
FDA Approval Summary: Erdafitinib for FGFR3-Altered Locally Advanced or Metastatic Urothelial Carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Regulatory cascade of NdpR and NdpR2 in controlling nicotine degradation operons in Sphingomonas melonis TY.
Applied and environmental microbiology·2026
Epidermal growth factor receptor as a target enzyme in cancer therapy: Structural and functional insights from crystallography.
Indian journal of pharmacology·2026
Mitigating Breast Cancer with Intratumoral In Situ pH-responsive Abemaciclib-loaded Novasome Hydrogel.
Journal of drug targeting·2026
Mechanisms and Predisposing Conditions for Statin-Induced New-Onset Type 2 Diabetes Mellitus: A Paradox Relative to Their Pleiotropic Metabolic Effects.
Endocrinology, diabetes & metabolism·2026